Tech Company Financing Transactions

Reprieve Cardiovascular Funding Round

Deerfield Management Company, Arboretum Ventures and Genesis Capital Growth participated in a $61 million Series B funding round for Reprieve Cardiovascular. The financing round was announced on 8/14/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

459 Fortune Blvd.
Milford, MA 01757
USA

Phone

(508) 541-8800

Website

www.reprievecardio.com

Email Address

[email protected]

Overview

Reprieve Cardiovascular is a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF). The company's Reprieve technology is being investigated as an innovative fluid management therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Alexander Martin

        

Chief Executive Officer

James Dillon

        

Chief Medical Officer

Howard Levin

        

Chief Technical Officer

Andrew Halpert

        

VP - Bus. Development

Gregory Mann

        

VP - Operations

Kenneth Luppi

        

Browse more venture capital transactions:

Prev: 8/13/2025: Smart Pension venture capital transaction
Next: 8/14/2025: Bumper venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary